INTRODUCTION:

Microspheres can be characterized as solid, approximately spherical particles with a diameter having between 1–1000μm, including dispersed drugs in certain solution or microcrystalline shape. Both the terms microcapsules and microspheres are often used as synonyms. ^[1]Medication That is simply transmitted in from gastrointestinal tract (GIT) and also has a short half-life is immediately destroyed from circulatory system in the blood. The oral sustained or controlled release (CR) have also been developed to avoid this problem, as that will Slowly discharge the substance into the GIT and retain a steady medication intensity in the plasma For a prolonged time period. A suitable dosage formulation is one that reaches the required plasma therapeutic Drug concentration and remains constant throughout the treatment period. This can be achieved by delivering a traditional dosage type in a fixed dose and at a specific frequency.^[2]A benefit they are not microcarriers over nanoparticles migrate across the range of 100 nm carried by the lymph into the interstitium, and therefore function locally. Probably toxic chemicals can be transported Encapsulated, and in place of liquid the dried microparticles may be known as solids. The intake dose is delivered in several tiny different for multiparticulate particles, which hold and discharge a part of the dosage; therefore the breakdown of a specific subunit does not affect the whole dosage failure. ^[3]Microparticles used in skin applications required to benefit the release of the mediction into the skin ensure that now the drug remains localized at the application site and does not enter the systemic circulation unnecessarily.^[4]They act as a reservoir which releases an active ingredient over a longer period of time to maintain effective concentration of drug products in the skin while decreasing undesired side effects. ^[5] Consequently, cycles of over- and under-medication are reduced. It is especially relevant for the reduction of antimicrobial resistance in the management of infectious diseases. These distribution mechanisms can also boost product safety or integration into appropriate vehicles.^[6,7]

Fig. No.-01 Microsphere

Fig. No.-02 Microsphere cross section

Advantages of Microspheres

A. Decrease of the size contributes to an increasing the surface area and can increase the potency of the poorly soluble material.

B. Providing a steady quantity of medications in the body that can improve patent compliance;

C. Dose and risk reduced.

D. Drug packaging with polymers prevents the drug avoid enzymatic cleavage while making it suitable for drug method delivery system.

E. Less duration of dosing contributes to higher patient compliance.

F. Effective usage of medications can enhance bioavailability, and decrease harmful effects occurrence or severity.

G. Helps protect the GIT from opioid irritants.

H. Transform liquid into solid shape and block the unpleasant taste.

I. Reliable means, if changed, to transmit the medication to the target location with precision and to sustain the targeted concentrations at the targeted site and with no undue impact.

J. Reduce central reactivity related to the external world.

K. Degradable microspheres get the benifit over large polymer implants through that they just do n't really necessarily involve medical treatments for implantation and reduction.

L. Controlled release delivery degradable microspheres are being used to regulate release of drug prices while also reducing toxicity, and reducing the discomfort of repeated injection.^[36]

Disadvantages of Microspheres

A. The changed releases from the formulations.

B. The release rate of the regulated dose process of release which differ from a number of Factors like diet and transfer levels through gut.

C. Variations in rate of discharge from one dosage to the next.

D. Controlled release formulations typically have a higher dose load and so any lack of quality of the release properties of the drug substance can contribute to

E. Potentially dangerous.

F. These dosing types must not be broken or chewed.^[37]

Materials used in the microsphere formulation

In the formulation of microsphere mainly used a polymers, they are classified as follows.

Ø Synthetic Polymers

Ø Natural polymers

A. Synthetic polymers are divided into two types

a) Non-biodegradable polymers

Example- Poly methyl methacrylate (PMMA), Acrolein Glycidyl methacrylate, Epoxy polymers

b) Biodegradable polymers-

Example- Lactides, Glycolides and their co polymers, Poly alkyl cyano acrylates, Poly anhydrides

B. Natural polymers-

They are obtained from different sourceslike proteins, carbohydrates and chemically modifiedcarbohydrates.They are also used a protein like Albumin, Gelatin, and Collagen, Carbohydrates like Agarose, Carrageenan, Chitosan, Starch and also Chemically changed carbohydrates used like Poly dextran, Poly starch.^{[8,9, 10]}

Types of microsphere

1) Bio-adhesive microspheres-

Adhesion can be characterized as adherence to the membrane by the use of theSticking the water soluble polymer properties. Bio-adhesive drug delivery system is delivery system uses the bioadhesion property of some of the polymers which become adhering on hydration and can be utilized for prolonged periods of time to direct a medication to a specific area of the body. Thus, the drug's absorption and therefore bioavailability is improved through the decreased dosing frequency resulting in greater compliance with the patient.^[11]

2) Magnetic microspheres

Magnetic microspheres are molecular particles which are tiny enough to move across capillaries without creating an esophageal occlusion (< 4μm) but are extremely sensitive (ferromagnetic) to be trapped in micro-vessels and drawn by a magnetic field of 0.5-0.8 tesla through neighboring tissues. Magnetic microspheres which locate the medication to the site of the disease are very essential. ^[12]

i. Therapeutic magnetic microspheres

^ii.Diagnostic microspheres

Fig. No.-03 Magnetic Micriosphere

3) Floating microspheres

Gastroretentive drug delivery methods are floating microspheres on the basis of non-effervescent design. The terminology used synonymously with floating microspheres is hollow microspheres, microballoons or floating microparticles. In a simple sense, floating microspheres are small, hollow objects with no center. These are free flowing cells, varying in scale from 1 to 1000 μm.^[13]

Fig. No. - 04 Floating Microsphere

4) Radioactive microspheres

The microsphere subgroup that is interacts radioactively and is typically treated in a comparable manner as non-radioactive microspheres. Yet the radioactive microsphere always includes one and sometimes more radio-nuclides, in addition to the matrix material that describes the microsphere and gives it its targeting properties in a particular tissue or organ. Also in low amounts, radioactive microspheres can carry large doses of radiation to a specific region without affecting the natural tissue surrounding them.^{[14, 15]}

Fig. No. 05– Radioactive Microsphere

5) Polymeric microspheres^[16,17]

The different types of polymeric microspheres can be classified as follows.

A. Biodegradable polymeric microspheres

B. Synthetic polymeric microspheres

Methods used in microsphere preparation

Choosing the method depends primarily on Character of a polymer been using, the drug, the factors equivocally determined by many formulations and technological factors as the size of the particles requirement, and the drug or protein should not be significantly impacted by the process, the reproducibility of the release profile and the method, there should be no stability Issue, in relation to the finished product. The various types of procedures used to prepare the microspheres using hydrophobic and hydrophilic polymers as matrix materials. ^[18]

· The capacity to integrate medication doses which are relatively small.

· Stability of preparation after synthesis with a shelf spam which is clinically acceptable.

· Controlled particle size and dispersibility for injection in the aqueous vehicles.

· Effective reagent release with strong control over a large time-scale.

· Biocompatibility of controllable biodegradability and chemical alteration response.

1. Wax coating and hot melt

Wax used to encapsulate the main components, by dissolving or dispersing the product in melted wax. The waxy paste or mixture, such as frozen liquid paraffin, is released by high intensity blending with cold water. The water is heated up for at least an hour. The substance is stirred up for at least 1 hour. Then the external layer (liquid paraffin) is decanted and the microspheres are immersed in a non-miscible solvent and dry air is required to dry. For the surface ingredients, carnauba wax and beeswax can be used and both should be combined to obtain desirable characteristics.^{[19, 21]}

2. Spray drying technique

This was used to prepare polymer microsphere mixed charged with drug. This requires dispersing the raw substance into liquefied coating liquid, and then spraying the mixture into the air for surface solidification accompanied by rapid solvent evaporation. Organic solvent and polymer solution are formulated and sprayed in various weight ratios and drug in specific laboratory conditions producing microspheres filled with medications. This is fast but may lose crystalinity due to rapid drying.

3. Coacervation

This method is a straight forward separation of macromolecular fluid into two immiscible types of material, a thick coacervate layer, comparatively condensed in macromolecules, and a distilled layer of equilibria. This method is referred to as basic coacervation, in the presence of just one macromolecule. If two or more opposite-charge macromolecules are involved, they are considered complex coacervation. The former is caused by specific factors including temperature shift,Using non-solvent or micro-ions contributing to dehydration in macromolecules, since they facilitate interactions between polymer and polymer through polymer solvent interactions. This can be engineered to generate different properties on microsphere.^[19]

4. Solvent evaporation

The method of solvent evaporation has also been extensively used to preparation of PLA and PLGA microspheres which contain many various drugs. Several variables were identified that can significantly affect microspheric characteristics, such as solubility of drug, internal morphology, type of solvent, diffusion rate , temperature, polymer composition as well as viscosity, and drug loading. The efficacy of the solvent evaporation system to create microspheres relies on the effective entanglement of the active substance into the particles, and therefore this procedure is particularly efficient with drugs that are either insoluble or partially soluble in the liquid medium that constitutes the constant phase. ^[22]

5. Precipitation

It is a modification of the form of evaporation. The emulsion is polar droplets scattered over a non-polar medium. The use of a co-solvent can extract solvent from the droplets. The subsequent rise in the concentration of polymers induces precipitation to create a microspheric suspension.^[23]

6. Freeze Drying

Freeze-drying is effectively used in protein API microspheres praparation. The method is freezing, sublimation, main drying, and secondary drying. At the freezing step, account is taken of the eutectic point of the components. During the process, lyoprotectants or cryoprotectants will stabilise API molecules by removing water, creating a glass matrix, lowering intermolecular interaction by forming hydrogen bonds between the molecules or dipole - dipole interactions. It's a beneficial cycle for heat tolerant molecules, given its high expense. Freeze-drying produces solidification and then enables the reconstitution of particles in an aqueous media.^[24]

7. Single Emulsion Solvent Evaporation Technique

This process requires polymer dissolution in an organic solvent accompanied by emulsification of an aqueous environment containing the emulsifying agent. The resulting emulsion is stirred for several hours in atmospheric conditions to allow the solvent to evaporate, which is then washed, rinsed and dried in desiccators. Designed and manufactured drugs microspheres with polymers by diffusion-evaporation method with emulsion solvent.^[25]

8. Double emulsification method

The Doppel-emulsion strategy requires mixing w / o / w or o / w / o processing the double emulsion. The aqueous solution of the product is distributed in a continuous lipophilic organic phase. The continuous step which consists of a polymer solution eventually encapsulates medication Observed in the scattered aqueous layer to form primary emulsion. Prior to introduction to the aqueous solution of alcohol to form primary emulsion, the pre-formed emulsion is subjected to homogenisation or sonication. The microspheres filled with the drug prolonged the release of the medication 24 hours and were Observed to be diffusion and erosion regulated.^[25]

9. Ionic gelation method

Ionotropic gelation is depend on the tendency of polyelectrolytes to cross connect to develop hydrogel beads often called gelispheres in the existence of counter ions. Gelispheres are Circular cross linked polymeric hydrophilic agent capable of substantial gelation and thickening in model biological fluids and drug release regulated by polymer relaxation via it. The hydrogel beads are formed by dumping a drug-laden polymeric solution into the polyvalent cations aqueous solution. The cations migrate through the drug-laden hydrophilic compounds, creating a three-dimensional lattice the moiety is ionically crosslinked. Biomolecules may also be placed into these gelispheres to maintain their three-dimensional form under moderate conditions.^[26]

Characterization of microsphere:

1. Particle size analysis

The dried microsphere were determined by microscopic method using calibrated optical micrometer, the most commonly used techniques for microparticular visualisation are standard light microscopy (LM).^{[28, 35]}

2. Scanning electron microscopy (SEM) study

The Samples were analyzed through SEM and it was well qualified from a back scattered electron sensor for image analysis and conducting the x - Ray diffraction analysis (EDXA) for elemental structure determination where particular elements have been identified. In this method the sample was scanned in parallel lines using a centered electron beam. Microspheres were then placed on a sample holder for SEM characterization preceded by coating with a conductive metal like platinum or zirconium using a sputter coater. The sample was then scanned with a guided, fine electron beam. The surface properties of the sample were derived from the secondary electrons leaked from the sample surface.^[29]

3. Flow properties

The flow properties can analysed by determining the carr's compressibility index , Hausner ratio and resting angle of repose. A volumetric cylinder was used to assess bulk density and tapped density.^[30]

4. Thermal analysis

Thermal analysis techniques analyse these changes routinely by applying scheduled variations in temperature for heating and cooling, as well as applying defined Specimen atmospheres and pressures. The most widely observed properties include subtle variations in heat and enthalpy, weight loss or weight gain, Young's modulus, thermal expansion or shrinkage and evolution of gas. ^[31]

5. Determination of percentage yield

The percentage yield can be determined by calculating the measured amount of the product and the polymers used in the formulation of the microspheres and the Overall sum ofv microspheres produced.^[32]

6. Drug content

The mixture should be held aside to allow the particles to sediment and then wash. 1mL was moved into volumetric flask from the filtrate, and the volume was balanced with 0.1N NaOH. Drug was measured spectrophotometrically after the correct dilution.^[33]

7. Determination of drug loading

Loading ability is the amount of drug loaded per unit nanoparticle weight, indicating the percentage of nanoparticle weight that is attached to the encapsulated product. Loading capacity (LC percent) can be determined by the total amount of drug trapped, divided by the total weight of nanoparticles. In the delivery of drugs, yield given as a percentage represents the amount of drug delivered per quantity. ^[34]

Application of Microspheres

A number of pharmaceuticalmicroencapsulated products are currently on the market.

1) Microspheres in vaccine delivery

The precondition of a vaccine is safety toward the microbes and its harmful component. An ideal vaccine should satisfy this same necessity of effectiveness, protection, affordability in application and charge. The aspect of protection and avoidance of severe effects is a complicated.The aspect of safeness and the extent of the manufacturing of antibody responses are intently linked to mode of application. Biodegradable delivery technology for vaccines which are provided by intravenous path may resolve the shortcoming of this same conventional vaccines. The involvement in parenteral (subcutaneous, intramuscular, intradermal) carrier exists even though those who offer significant benefits.^[38]

2) Microspheres in Gene delivery

Genotype drug delivery involves viral vectors, nonionic liposomes, polycation complexes, and microcapsules technologies. Viral vectors are beneficial for genotype delivery even though those who are extremely efficient and also have a broad variety of cell goals. Even so, if used in vivo they trigger immune responses and pathogenic effects. To resolve the restrictions of viral vectors, nonviral delivery systems have been regarded for gene therapy. Nonviral delivery system does have benefits these as simplicity of preparation, cell / tissue targeting, reduced immune system, unrestricted plasmid size, as well as large-scale replicable production. Polymer will be used as a transporter of DNA for gene delivery applications.^[38,39]

3) Oral drug delivery

The potential of polymer matrix usually contains diazepam like an oral drug delivery has been evaluated through rabbits. Its findings showed that even a film consisting of a 1:0.5 drug-polymer combination may have been an effectual dosage form which is comparable to commercial tablet formulations. The capacity of polymer to establish films could allow use in the formulation of film dosage forms, as an option with drug tablets. The pH sensitivity, combined with both the reactions of the main amine groups, start making polymer a distinctive polymer for oral drug delivery applications. ^[40]

4) Transdermal drug delivery

Polymer has good film-forming characteristics. The release profile from of the devices is impacted by the membrane thickness as well as crosslinking of a film. Chitosan-alginate polyelectrolyte structure has also been prepared in-situ in beads and microspheres for potential uses in packaging, controlled release systems and surgical instruments. Polymer gel beads are an impressive highly biocompatible vehicle for chemotherapy of inflammatory cytokines for medications like prednisolone that also showed extended release action enhancing treatment effectiveness. The amount of drug discharge was found to also be depend on the characteristics of cell wall used. A mixture of chitosan membrane and chitosan hydrogel known to contain lidocaine hydrochloride, a local anaesthetic is a great comprehensive process for controlled drug release and release kinetics.^[41]

5) Targeting by Using Micro Particulate Carriers

The principle of trying to target is a well established dogma, that is trying to gain huge interest present a days. The response manufactured by drug depends itself on availability and ability to interact to binding site generally pellets technique is confirmed that can be formulated by utilising extrusion / Spheronization innovation e.g. microcrystalline cellulose (MCC) and chitosan.^[42]

6) Monoclonal Antibodies

Monoclonal antibodies or targeting microspheres are physiologically immunologic microspheres. One such type of trying to target is having been using to accomplish selective targeting to particular sites of an organ system. Monoclonal Antibodies are highly precise compounds that also bind to a particular portion of the body structure via which uptake occurs via^[42,
43]

a. Non particular adsorption and particular adsorption

b. Direct coupling

c. Coupling via reagent

7) Intratumoral and local drug delivery

In order to achieve solid lipid nanoparticles at the tumour cells in therapeutically relevant intensity, polymer films were also manufactured. Combination with medication does have promising potential to be used in controlled delivery throughout the oral cavity. Eg. Gelatin, PLGA, Chitosan and PCL.^[44]

8) Other applications

Microspheres are used for membrane technology developed for mass spectrometry, cell biology, cell biology; Fluorescent connected Immuno-Sorbent Assay. Yttrium could be used for standard treatment of hepatocellular carcinoma and even used besides pre transplant management of HCC with promising results. Applications of microencapsulation in other industry sectors are various. Carbonless copying paper, photosensitive paper, microencapsulated fragrances such as "scent-strips" (also known as "snap-n-burst") and microencapsulated aromas ("scratch-n-sniff"') are the best known microencapsulated products. These other products are usually prepared by the use of gelatin – acacia coacervation complex. Scratch-n-sniff has been used in children's literature and in the development of nutrition and cosmetics fragrance advertising. Microcapsules also are heavily included as diagnostic tests, for example, temperature-sensitive microcapsules for temperature dependent visual detection of cancer. In the biotech industry microcapsules microbial cells are used for the production of recombinant and proteins.^[45]

CONCLUSION:

The present review article that is microspheres are better of drug delivery system than other type of drug delivery system. In upcoming days this microsphere novel drug delivery system which shows more effective in cancer therapy or in any other disease treatment like a pulmonary related, cardiac related, nervous system related this microsphere formulation shows more potency this having more effective in in-vivo delivery system. Mainly this formulation gives safety to the active pharmaceutical ingredient and also other excipients used in formulation.

REFERENCES:

1. B. Venkateswara Reddy. et. al., Formulation and evaluation of efavirenz microspheres, Der Pharmacia Lettre, 2015, 7 (6):1-9.

2. S. M. Sarode, et. al., Formulation and evaluation of floating microspheres of Glipizide, Journal of Chemical and Pharmaceutical Research, 2011, 3(3):775-783.

3. Miléna Lengyel, Review Microparticles, Microspheres, and Microcapsules for Advanced Drug Delivery, Scientia. Pharmaceutica. 2019, 87- 20.

4. Badilli U, Sen T, Tarimci N. Microparticulate based topical delivery system of Clobetasol Propionate. AAPS PharmSciTech 2011, 12, 949-57.

5. Basarkar G, Shirsath G, Patil S. Development of microspheres containing Diclofenacdiethylamine as sustained release topical formulation. Bull Pharm Res 2013, 3, 14-22.

6. Labouta H, El-Khordagui L. Polymethacrylate microparticles gel for topical drug delivery. Pharm Res 2010; 27:2106-18.

7. S. Y. RAI, et. al., Development and Evaluation of Microsphere-based Topical Formulation using Design of Experiments, Indian Journal of Pharmaceutical Sciences, 2016;78(2):182-192

8. Tsuyoshi Kojima, et. al., Preparation and Evaluation in Vitro of Polycarbonate Microspheres Containing Local Anesthetics, Chemical and Pharmaceutical Bulletin, 1984, 32(7) Pages 2795-2802.

9. Alagusundaram.M, et. al., Microspheres as a Novel Drug Delivery Sysytem - A Review, International Journal of Chem Tech Research, 2009, 1 (3), Page 526-534.

10. M. Okubo, et. al., Production of submicron-size monodisperse polymer particles having aldehyde groups by seeded aldol condensation polymerization, Colloid and Polymer Science, 1993, 271, Pages109–113.

11. Pawan Chaware, et. al., Bioadhesive Microspheres: A Review On Preparation And In-Vitro Characterization, World Journal of Pharmaceutical Research, 4, (2), 423-436.

12. Farah Hamad Farah, et. al., Magnetic Microspheres: A Novel Drug Delivery System, Analytical and Pharmaceutical Research, 2016 3 (5), Page 1-10.

13. Jagtap Yogesh Mukund, et. al., Floating microspheres: a review, Brazilian Journal of Pharmaceutical Sciences, 2012, 48 (1), Page 17-30.

14. Urs Häfeli, et. al., Review: Radioactive Microspheres for Medical Applicationsm, Cleveland Clinic Foundation, Radiation Oncology Department T28, page 1-29.

15. Lachman LA, Liberman HA, Kanig JL. The Theory and Practice of Industrial Pharmacy. Varghese Publishng House, Mumbai, India: 1991, 3rd edition; P-414-415.

16. Ando S, Putnam D, Pack DW, and Langer R. PLGA Microspheres Containing Plasmid DNA: Preservation of Super coiled DNA via Cry preparation and Carbohydrate Stabilization. J. Pharmaceut. Sci.1998;88(1): 126– 130.

17. Ketie Saralidze, et. al., Polymeric Microspheres for Medical Applications, Materials, 2010, 3, Page 3537-3564.

18. E Veena Rani, et. al., Preparation and Evaluation of Aspirin Loaded Microspheres by Solvent Evaporation Technique, Journal of Medicine and Biology, 2019, 1 (1), Page 27- 32.

19. Saravana Kumar K, et. al., A Review on Microsphere for Novel drug delivery System, Journal of Pharmacy Research, 2012,5(1), Page 420-424.

20. Venkatesan PC, Manavalan R, and Valliappan K, Selection of better method for the preparation of microspheres by applying Analytic Hierarchy Process. J. Pharm. Sci. and Res. 2009; Vol.1 (3): P- 64-78.

21. Harsh Bansal, et. al., Microsphere: Methods of Prepration and Applications; a Comparative Study, International Journal of Pharmaceutical Sciences Review and Research, 2011, 10(1); Article-012.

22. Patrick B. O’Donnell, et. al., Preparation of microspheres by the solvent evaporation technique, Advanced Drug Delivery Reviews 28 (1997) Page 25–42.

23. Tibor Renkecz, et. al., Preparation of Molecularly Imprinted Microspheres by Precipitation Polymerization, Methods in Molecular Biology, 2017, 1575, Page 341-352.

24. Xinghang Ma, et. al., Stability Study of Drugloaded Proteinoid Microsphere Formulations during Freeze-drying, Iournal of Drug Targeting, 1994, 2, Page 9-21.

25. Shweta Saini, et. al., Microspheres as Controlled Drug Delivery System: An Updated Review, international journal of pharmaceutical science and research,4, 2018, 1760-1768.

26. Poonam Patil, rt. al., A Review on Ionotropic Gelation Method: Novel Approach for Controlled Gastroretentive Gelispheres, International Journal of Pharmacy and Pharmaceutical Sciences, 2012, 4 (4), 27-32.

27. Bhutkar Mangesh A., et. al., Development and Characterization of Lornoxicam loaded microsponge gel for Rheumatoid arthritis, 2019, 9 (3), Page 173-178.

28. Kadam N. R., et. al., Microspheres: A Brief Review, Asian Journal of Biomedical and Pharmaceutical Sciences, 2015, 5(47), Page 13-19.

29. Patitapabana Parida, et. al., Development and characterization of ethylcellulose based microsphere for sustained release of nifedipine, journal of pharmaceutical analysis, 2016, 6(5), Page 341-344.

30. Navid Jubaer Ayon, et. al., Preparation and Characterization of Gliclazide Incorporated Cellulosic Microspheres: Studies on Drug Release, Compatibility and Micromeritics, Dhaka Univ. J. Pharm. Sci., 2014, 13(2), Page 149-166.

31. Rakesh Gupta, et. al., Characterization of Captopril-Ethyl Cellulose Microspheres by Thermal Analysis, International Journal of Drug Development and Research April-June 2010, 2(2), Page 394-398.

32. Abhay M.L, et. al., Formulationa and Characterization of Microspheres of Artemether, Literati Journal of Pharmaceutical Drug Delivery Technologies, 2015, 1(2), Page 65-69.

33. Venkatesh D. P, et. al., Formulation and Evaluation of Microspheres Containing Fluvastatin Sodium, International Journal of Drug Development and Research, 2012, 4(2): Pag306-314.

34. Sanjay dey, et. al., Formulation and Optimization of Sustained Release Stavudine Microspheres Using Response Surface Methodology, International Scholarly Research Notices, 2011, pages 1-7.

35. Gauravkumar R. Agrawal, et. al, Formulation, physicochemical characterization and in vitro evaluation of human insulin-loaded microspheres as potential oral carrier, Prog Biomater (2017) 6:125–136.

36. Tarun Virmani, et. al., Pharmaceutical Application of Microspheres: An Approach for The Treatment of Various Diseases, International Journal of Pharmaceutical Sciences and Research, 2017, 7 Page 3252-3260.

37. B. Sree Giri Prasad, et. al., Microspheres as Drug Delivery System – A Review, Journal of Global Trends in Pharmaceutical Sciences, (2014), 5(3), Page 1961–1972.

38. Abbaraju Krishna shailaja, et. al., Biomedical applications of microspheres, Journal of Modern Drug Discovery and Drug Delivery Research, 2015, 4 (2), Page 1-5.

39. Kazi M. Zakir Hossain, et. al., Development of microspheres for biomedical applications: a review, Prog Biomater, 2014, Page 1-19.

40. Kataria Sahil, et. al., Microsphere: A Review, International Journal of Research in Pharmacy and Chemistry, 2011, 1(4), Page 1184-1198.

41. Reza Arshady, et. al., Microspheres for biomedical applications: preparation of reactive and labeled microsphere, biomaterials, 1993, 14(1), Page 5-15.

42. Tarun Virman, et. al., Pharmaceutical Application Of Microspheres: An Approach For The Treatment Of Various Diseases, International Journal of Pharmaceutical Science and Reaserch, 2017; Vol. 8(8): 3252-3260.

43. MK Shahzad, et. al., Formulation and Optimization of Celecoxib-Loaded Microspheres Using Response Surface Methodology, Tropical Journal of Pharmaceutical Research, 2012, 11 (5), Page 695-702.

44. Kadam N, et. al., Microspheres: A Brief Review, Asian Journal of Biomedical and Pharmaceutical Sciences, 2015, 5(47), Page 13-19.

45. Manoj Kumar Das, Microsphere a Drug Delivery System–A Review, International Journal of Current Pharmaceutical Research, 2019 11(4), Page 34-41.

Received on 17.09.2020 Modified on 18.10.2020

Asian Journal of Pharmacy and Technology. 2021; 11(2):149-155.

DOI: 10.52711/2231-5713.2021.00025